How long does APICA last?

The total duration of APICA via smoked is 30 minutes to 1 hour. Onset typically occurs within 20 seconds. Peak effects last 10 minutes to 30 minutes.

APICA — SubstanceWiki

APICA (N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide; also known as 2NE1 and SDB-001) is a synthetic cannabinoid receptor agonist belonging to the indole carboxamide class. It is structurally characterized by an indole core linked to a carboxamide with an adamantyl (adamantane) head group and a pentyl alkyl chain. APICA acts as a full agonist at both CB1 and CB2 receptors, with potency in the same range as JWH-018 and substantially greater than THC.

APICA appeared in research chemical and synthetic cannabinoid markets in the early 2010s, typically found in herbal smoking products. Like all potent full-agonist synthetic cannabinoids, APICA carries a substantially elevated risk profile compared to cannabis — seizures, acute psychosis, cardiovascular toxicity, and documented fatalities have been attributed to synthetic cannabinoid products containing indole carboxamide class compounds. The adamantyl head group is shared with several other synthetic cannabinoids and is associated with high CB1/CB2 potency relative to simpler alkyl groups.

Harm Reduction

Avoid Synthetic Cannabinoids The safest harm-reduction position is complete avoidance of synthetic cannabinoid products. If harm reduction for users who choose to use is the goal: Use in the presence ...

How It Feels

APICA delivers a cannabinoid experience with a sharp, focused onset that cuts through consciousness like a blade. Seconds after inhalation, a tightness grips the head -- not painful exactly, but insistent, a pressure that announces the compound's arrival with none of the gentle warmth that natural cannabis typically provides as a prelude. The eyes feel strained, as though someone has turned up the brightness on the visual field without adjusting the contrast. A metallic taste may linger on the tongue.

The high develops quickly into a state that occupies uneasy territory between cannabis-like intoxication and something harder to categorize. There is sedation, but it carries a rigid quality, the body growing heavy and still without the melting, comfortable surrender that characterizes indica strains. The muscles tighten subtly rather than release. The jaw clenches. There is a synthetic stiffness to the physical state, as though the body has been locked into a position of rest rather than invited into one.

Mentally, APICA produces a fragmented, loop-prone cognitive state. Thoughts repeat without progression, circling back to the same observation or sensation with mechanical persistence. Short-term memory is severely impaired, making conversation difficult and sustained reasoning nearly impossible. There is a dissociative quality that separates you from your emotional responses -- events register intellectually but fail to produce proportional feelings, as though the connection between perception and affect has been partially severed. Time slows to an excruciating crawl, each moment dense and overlong.

The sensory shifts are sharp-edged and unsettling. Colors appear vivid but with an artificial quality, as though they have been digitally enhanced. Sounds may become distorted, gaining echoes or harmonic overtones that were not present in the original stimulus. There is a heightened sensitivity to physical sensation that is not always pleasant -- textures feel exaggerated, temperature shifts register with unusual intensity, and the heartbeat becomes a prominent, sometimes alarming presence in the chest.

The duration is one to two hours for primary effects, though the decline can leave residual effects -- foggy thinking, mild anxiety, headache -- for several hours beyond. The comedown has a draining quality, the sharp-edged high giving way to a flat exhaustion that feels like it has been purchased at the cost of the preceding hour's intensity. Appetite may surge or crater. Sleep is achievable but often shallow, and waking brings a heaviness that takes time and hydration to dispel.

Subjective Effects

The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.

Physical Effects

Physical(11)

Appetite enhancement— A distinct increase in hunger and desire for food, often accompanied by enhanced enjoyment of taste ...
Changes in felt gravity— A distortion of one's proprioceptive sense of gravity in which the perceived direction of gravitatio...
Dehydration— A state of insufficient bodily hydration manifesting as persistent thirst, dry mouth, and physical d...
Dry mouth— A persistent, uncomfortable reduction in saliva production causing the mouth and throat to feel parc...
Headache— A painful sensation of pressure, throbbing, or aching in the head that can range from a dull backgro...
Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
Motor control loss— A distinct decrease in the ability to control one's physical body with precision, balance, and coord...
Pain relief— A suppression of negative physical sensations such as aches and pains, ranging from dulled awareness...
Physical euphoria— An intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity...
Respiratory depression— A dangerous slowing and shallowing of breathing that can progress from barely noticeable reductions ...
Sedation— A state of deep physical and mental calming that manifests as a progressive desire to remain still, ...

Cognitive & Perceptual Effects

Cognitive(6)

Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
Conceptual thinking— A shift in the nature of thought from verbal, linear sentence structures to intuitive, non-linguisti...
Depression— A persistent state of low mood, emotional numbness, hopelessness, and diminished interest or pleasur...
Paranoia— Irrational suspicion and belief that others are watching, plotting against, or intending harm toward...
Thought connectivity— A state in which disparate thoughts, concepts, and ideas become fluidly and spontaneously interconne...

Detection Methods

Standard Drug Panel Inclusion

APICA (SDB-001) is a synthetic cannabinoid receptor agonist that is not detected on standard 5-panel drug screens. Standard THC immunoassays target 11-nor-9-carboxy-THC (THC-COOH), the primary metabolite of delta-9-THC, and do not cross-react with synthetic cannabinoids. Some expanded drug panels (12-panel or custom panels) include a synthetic cannabinoid channel, but coverage of specific compounds varies widely between manufacturers.

Urine Detection

APICA (SDB-001) and its metabolites can be detected in urine for approximately 2 to 5 days after a single use, though chronic heavy use can extend this window to 7 or more days. Synthetic cannabinoids undergo extensive hepatic metabolism, primarily via hydroxylation and carboxylation, producing metabolites that are excreted in urine as glucuronide conjugates. The specific metabolite profile varies by compound and is a key factor in whether a given immunoassay can detect APICA (SDB-001).

Blood and Saliva Detection

Blood concentrations of APICA (SDB-001) decline rapidly after use, with a detection window of approximately 12 to 48 hours for the parent compound. Metabolites may persist longer. Oral fluid testing can detect parent compound and early metabolites for approximately 24 to 48 hours, and some roadside testing devices include synthetic cannabinoid panels.

Hair Follicle Detection

Hair follicle analysis can detect synthetic cannabinoids for up to 90 days. However, incorporation rates and detectability vary by compound. Some laboratories offer expanded hair panels that include common synthetic cannabinoids such as JWH-018 and AB-FUBINACA metabolites, but coverage of newer compounds including APICA (SDB-001) may be limited.

Confirmatory Testing

LC-MS/MS is the preferred confirmatory method for synthetic cannabinoids. The structural diversity and rapid evolution of this substance class means that reference standards must be available for the specific compound under investigation. GC-MS can also be used but LC-MS/MS offers superior sensitivity and specificity for the typically low concentrations encountered. Both parent compound and key metabolites should be targeted.

Reagent Testing

Standard reagent tests (Marquis, Mecke, Mandelin) are generally uninformative for synthetic cannabinoids, as these compounds are typically applied to herbal material at very low concentrations and produce no characteristic color reactions. Visual inspection and reagent testing cannot distinguish treated herbal material from untreated plant matter. Immunoassay-based test strips specific to synthetic cannabinoids are available from some harm reduction suppliers and represent a more practical point-of-use screening option.

Interactions

Substance	Status	Note
1,3-Butanediol	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
1,4-Butanediol	Caution	Increased sedation and cognitive impairment
1B-LSD	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
1cP-AL-LAD	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
1cP-LSD	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
1cP-MiPLA	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
1P-ETH-LAD	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
1P-LSD	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
1V-LSD	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2-Fluorodeschloroketamine	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
2,5-DMA	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
25B-NBOH	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
25B-NBOMe	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
25C-NBOH	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
25C-NBOMe	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
25D-NBOMe	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
25E-NBOH	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
25I-NBOH	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
25I-NBOMe	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
25N-NBOMe	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2C-B	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2C-B-FLY	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2C-C	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2C-D	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2C-E	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2C-H	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2C-I	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2C-P	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2C-T	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2C-T-2	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2C-T-21	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2C-T-7	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2M2B	Caution	Increased sedation and cognitive impairment
3-Cl-PCP	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
3-HO-PCE	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
3-HO-PCP	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
3-MeO-PCE	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
3-MeO-PCMo	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
3-MeO-PCP	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
3C-E	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
3C-P	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
4-AcO-DET	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
4-AcO-DiPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
4-AcO-DMT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
4-AcO-MET	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
4-AcO-MiPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
4-HO-DET	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
4-HO-DiPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
4-HO-DPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
4-HO-EPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
4-HO-MET	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
4-HO-MiPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
4-HO-MPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
4-MeO-PCP	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
5-MeO-DALT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
5-MeO-DiBF	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
5-MeO-DiPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
5-MeO-DMT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
5-MeO-MiPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
6-APB	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
AL-LAD	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Alcohol	Caution	Increased sedation and cognitive impairment
ALD-52	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Allylescaline	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Alprazolam	Caution	Increased sedation and cognitive impairment
Ayahuasca	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Baclofen	Caution	Increased sedation and cognitive impairment
Benzodiazepines	Caution	Increased sedation and cognitive impairment
Bromo-DragonFLY	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Bufotenin	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Cake	Caution	Increased sedation and cognitive impairment
Carisoprodol	Caution	Increased sedation and cognitive impairment
Clonazepam	Caution	Increased sedation and cognitive impairment
Clonazolam	Caution	Increased sedation and cognitive impairment
Clonidine	Caution	Increased sedation and cognitive impairment
Deschloroetizolam	Caution	Increased sedation and cognitive impairment
Deschloroketamine	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
DET	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Dextromethorphan	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
Diazepam	Caution	Increased sedation and cognitive impairment
Diclazepam	Caution	Increased sedation and cognitive impairment
Diphenidine	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
DiPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
DMT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
DOB	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
DOC	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
DOI	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
DOM	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
DPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Efavirenz	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Ephenidine	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
EPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Escaline	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Eszopiclone	Caution	Increased sedation and cognitive impairment
ETH-LAD	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Etizolam	Caution	Increased sedation and cognitive impairment
F-Phenibut	Caution	Increased sedation and cognitive impairment
Flualprazolam	Caution	Increased sedation and cognitive impairment
Flubromazepam	Caution	Increased sedation and cognitive impairment
Flubromazolam	Caution	Increased sedation and cognitive impairment
Flunitrazepam	Caution	Increased sedation and cognitive impairment
Flunitrazolam	Caution	Increased sedation and cognitive impairment
Gabapentin	Caution	Increased sedation and cognitive impairment
Gaboxadol	Caution	Increased sedation and cognitive impairment
GBL	Caution	Increased sedation and cognitive impairment
GHB	Caution	Increased sedation and cognitive impairment
Grayanotoxin	Caution	Increased sedation and cognitive impairment
HXE	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
Ibogaine	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Inhalants	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
Ketamine	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
LAE-32	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Lorazepam	Caution	Increased sedation and cognitive impairment
LSA	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
LSD	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
LSM-775	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
LSZ	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
MDA	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Memantine	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
Mephenaqualone	Caution	Increased sedation and cognitive impairment
Mescaline	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
MET	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Methallylescaline	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Methaqualone	Caution	Increased sedation and cognitive impairment
Methoxetamine	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
Methoxphenidine	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
Metizolam	Caution	Increased sedation and cognitive impairment
Midazolam	Caution	Increased sedation and cognitive impairment
MiPLA	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
MiPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Mirtazapine	Caution	Increased sedation and cognitive impairment
MPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
MXiPr	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
Nicotine	Caution	Increased sedation and cognitive impairment
Nifoxipam	Caution	Increased sedation and cognitive impairment
Nitrous	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
O-PCE	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
PARGY-LAD	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
PCE	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
PCP	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
Pentobarbital	Caution	Increased sedation and cognitive impairment
Phenobarbital	Caution	Increased sedation and cognitive impairment
PRO-LAD	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Psilocybin Mushrooms	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
SAMe	Caution	Increased sedation and cognitive impairment

Toxicity & Safety

Full Agonist Toxicity

APICA shares the full synthetic cannabinoid toxicity profile: cardiovascular events (tachycardia, arrhythmia, myocardial stress), seizures, acute psychotic episodes, renal complications, and respiratory depression at high doses. These effects are qualitatively different from cannabis toxicity and can manifest at doses that produce only mild-to-moderate intoxication in experienced users due to the full agonism.

Psychotic Episodes

Indole carboxamide synthetic cannabinoids are documented in emergency medicine literature as causes of acute psychotic episodes. These episodes may include paranoid ideation, formal thought disorder, aggression, and hallucinations. While typically resolving with supportive care, persistent psychosis following synthetic cannabinoid exposure has been documented, particularly in individuals with vulnerability to psychosis.

Unknown Long-Term Profile

APICA's long-term toxicity in humans has not been studied. Chronic CB1 activation at the potency levels achievable with full agonists may produce receptor downregulation, tolerance, and dependence more severe than with cannabis, but specific data are lacking.

Addiction Potential

moderately addictive with a high potential for abuse

Overdose Information

Fatal overdose from natural cannabis (THC) alone has not been documented. However, synthetic cannabinoids can cause life-threatening overdose, and even natural cannabis can produce acute medical events requiring attention.Natural cannabis — acute adverse reactions:

Severe anxiety/panic attacks
Transient psychotic episodes (paranoia, hallucinations)
Vasovagal syncope (fainting)
Tachycardia (rarely, cardiac events in predisposed individuals)
Cannabis Hyperemesis Syndrome (cyclic severe vomiting with chronic heavy use)

Synthetic cannabinoid overdose (medical emergency):

Seizures, loss of consciousness
Severe agitation or psychosis
Chest pain, rapid irregular heartbeat
Difficulty breathing
Acute kidney injury

Response: For natural cannabis adverse reactions, reassurance and a calm environment usually suffice ("you're safe, this will pass"). For synthetic cannabinoid emergencies, call emergency services immediately.

Full	develops with prolonged and repeated use
Half	3 - 7 days
Zero	1 - 2 weeks

APICA

Quick Dosage

Dosage

smoked

Duration

smoked

How It Feels

Subjective Effects

Physical Effects

Physical(11)

Cognitive & Perceptual Effects

Cognitive(6)

Pharmacology

Mechanism of Action

In Vivo Potency

Adamantyl Group Pharmacology

Pharmacokinetics

Detection Methods

Standard Drug Panel Inclusion

Urine Detection

Blood and Saliva Detection

Hair Follicle Detection

Confirmatory Testing

Reagent Testing

Interactions

History

Development and Market Entry

Legal Control

Harm Reduction

Avoid Synthetic Cannabinoids

Product Labeling Is Unreliable

Emergency Response

Toxicity & Safety

Full Agonist Toxicity

Psychotic Episodes

Unknown Long-Term Profile

Addiction Potential

Overdose Information

Tolerance

Cross-tolerances

Legal Status

Experience Reports (2)

Tips (5)

See Also

References (4)

Frequently Asked Questions